Getty Images (NYSE:GETY) shares climbed almost 6% following the company’s third-quarter 2025 earnings report, as the company delivered results that exceeded Wall Street expectations despite largely unchanged revenue from the prior year.
The company reported revenue of $240 million for the quarter, down 0.2% year over year, in line with analyst estimates.
Adjusted earnings per share came in at $0.08, well above the consensus of $0.04.
Net income rose to $21.6 million, compared with a net loss of $2.5 million in the same quarter last year.
The company’s annual subscription revenue continued to grow, rising 11.2% year over year to account for 58.4% of total revenue.
Creative revenue increased 8.4% to $144.9 million, while editorial revenue declined 3.7% to $89.3 million.
Profitability remained strong, with a net income margin of 9.0% and an adjusted EBITDA margin of 32.8%.
Adjusted EBITDA totaled $78.7 million, down slightly from the prior year, while adjusted EBITDA minus capital expenditures came in at $64 million.
Getty Images also updated its full-year 2025 guidance. Revenue is now expected between $942 million and $951 million, higher than prior guidance of $931 million to $968 million.
Adjusted EBITDA guidance was revised to $291 million to $293 million, narrowing the expected year-over-year decline.
Following the report, Wedbush analysts maintained an ‘Outperform’ rating on Getty, with a 12-month price target of $7.
“A quality quarterly report and raised EBITDA guidance, along with some clarity on the recently announced Perplexity licensing agreement, give us confidence in the core company as it awaits regulatory approval for the Shutterstock merger in 2026,” they wrote.
They noted that the Perplexity deal is positive for Getty, as “proper, legal attribution for Getty’s high-quality images is at the core of the deal, thus preserving Getty’s moat,” while also generating revenue and benefiting Getty on a standalone basis or combined with Shutterstock.
The analysts concluded Getty remains on a positive trajectory despite the CMA’s decision to extend the merger review, noting that the deal is still expected to clear regulatory hurdles in 2026.